JomCare Study - A Harm Reduction Study

Chemsex, the use of psychoactive drugs before or during sexual activity, is a growing public health concern associated with striking increases in HIV, particularly among men who have sex with men (MSM). This study proposes to optimize an app-based just-in-time adaptive intervention, called JomCare, which aims to reduce chemsex risk by delivering tailored support when a person is most likely to be vulnerable to chemsex risk behaviors and receptive to intervention, with the purpose of reducing risk and averting new HIV infections.

NCT Number	NCT06794840
Lead Sponsor	University of Connecticut Collaborators: University of Malaya, Yale University, National Institute on Drug Abuse (NIDA), University of Michigan, University of Texas at Tyler, Ohio State University
Conditions	HIV, Substance Abuse Disorder
Enrollment	482 participants
Start Date	2026-04-01
Primary Completion	2029-05-30 (estimated)
Study Completion	2029-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-23